PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)

Clinical trial NCT06750432 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06750432
Sponsor: ProMis Neurosciences, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease, Early Onset

Start date: 2024-12-13
Primary completion: 2026-12-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.